Medical Specialty Bags Market Report 2026

Medical Specialty Bags Market Overview

• Medical Specialty Bags market size has reached to $8.76 billion in 2025 • Expected to grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 5.8% • Growth Driver: Rising Prevalence Of Chronic Diseases Fuels Expansion Of The Medical Specialty Bags Market • Market Trend: Endo Launches First FDA-Approved Ready-to-Use Epinephrine IV Bag • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Medical Specialty Bags Market?

Medical specialty bags refer to a category of specialized bags or pouches that are used in the medical field for various purposes. These bags are generally used in hospitals to keep blood stored in sterile conditions and to provide patients with nourishment during operations and other crucial situations. The main products of medical specialty bags are intravenous fluid bags, ostomy bags, sterile packaging bags, continuous ambulatory peritoneal dialysis bags (CAPD), anesthesia and resuscitation bags and others. Intravenous fluid bags refer to IV bags as a thin tube that is connected to an intravenous line and is made up of sterile materials used to deliver fluids, medications and nutrients directly into a patient's bloodstream and prevent dehydration. They are made of various materials including polyvinyl chloride (PVC) compounds, polyolefins and others used by various end-users such as hospitals, ambulatory surgical centers, home healthcare and others.

What Is The Medical Specialty Bags Market Growth Forecast?

The medical specialty bags market size is expected to see strong growth in the next few years. It will grow to $11.52 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing focus on sustainable medical packaging, rising demand from home healthcare settings, expansion of chronic disease management, growing investments in advanced material technologies, increasing regulatory emphasis on patient safety. Major trends in the forecast period include increasing demand for non-pvc medical bags, rising adoption of single-use sterile packaging solutions, growing focus on enhanced patient safety and infection control, expansion of specialized dialysis and blood storage bags, improved material performance and shelf-life stability.

Global Medical Specialty Bags Market Segmentation

1) By Product: Intravenous Fluid Bags, Ostomy Bags, Sterile Packaging Bags, Continuous Ambulatory Peritoneal Dialysis Bags (CAPD), Anesthesia And Resuscitation Bags, Other Products 2) By Material: Polyvinyl Chloride (PVC) Compounds, Polyolefins, Other Materials 3) By End-User: Hospitals, Ambulatory Surgical Centers, Home Healthcare, Other End-Users Subsegments: 1) By Intravenous Fluid Bags: PVC IV Bags, Non-PVC IV Bags, Combination IV Bags 2) By Ostomy Bags: Colostomy Bags, Ileostomy Bags, Urostomy Bags 3) By Sterile Packaging Bags: Pouch Bags, Roll Bags, Custom Sterile Packaging Bags 4) By Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags: Standard CAPD Bags, CAPD Bags With Integrated Filters, Specialty CAPD Bags 5) By Anesthesia And Resuscitation Bags: Manual Resuscitators (Ambu Bags), Anesthesia Breathing Circuits, Disposable Anesthesia Bags 6) By Other Products: Drainage Bags, Blood Bags, Collection Bags

What Is The Driver Of The Medical Specialty Bags Market?

The increasing number of chronic diseases is expected to propel the growth of the medical specialty bags market going forward. Chronic diseases are medical conditions that persist over an extended period of time, often for a person's lifetime. Medical specialty bags play a crucial role in the treatment and management of chronic diseases. medical specialty bags are designed to meet specific medical needs and provide essential support in various aspects of patient care. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing number of chronic diseases is driving the growth of the medical specialty bags industry.

Key Players In The Global Medical Specialty Bags Market

Major companies operating in the medical specialty bags market are Pall Corporation, Fresenius Medical Care AG & Co., Baxter International Inc., B. Braun Medical Inc., Terumo Corporation, Becton Dickinson & Company, C. R. Bard Inc., Hollister Incorporated, Coloplast Corp., Convatec Inc., Nolato AB, Custom Pack Inc., Ambu A/S, Macopharma Inc., Technoflex EN, JMS North America Corporation, Narang Medical Limited, AdvaCare Pharma, Westfield Medical Ltd., Sippex, BL Lifesciences, Kawasumi Laboratories America Inc., Armand Manufacturing Inc., Uniflex Healthcare

Global Medical Specialty Bags Market Trends and Insights

Major companies operating in the medical specialty bags market are focusing on technological innovation, such as FDA-approved, ready-to-use premixed intravenous (IV) bags, which enhance workflow efficiency, reduce preparation errors, and optimize patient safety in critical care settings. Ready-to-use premixed IV bags integrate pre-mixed medications, single-port tubing, and extended shelf life to streamline hospital operations, eliminate compounding steps, reduce waste, and minimize the risk of medication errors. For instance, in December 2024, Endo, Inc., a US-based pharmaceutical and medical device company, launched the ADRENALIN Ready-to-Use Premixed Bag, the first and only FDA-approved manufacturer-prepared epinephrine IV bag. The product eliminates the need for compounding or mixing, features single-port IV tubing to prevent inadvertent medication addition, and offers a 24-month shelf life at room temperature, providing hospitals with a safer, faster, and more convenient solution for emergency and critical care administration.

What Are Latest Mergers And Acquisitions In The Medical Specialty Bags Market?

In March 2023, Vonco LLC, a US-based medical device manufacturing company, acquired Genesis Plastics Welding for an undisclosed amount. With this acquisition of Genesis Plastics Welding, Vonco will provide service and value to clients seeking specialty medical devices, fluid bags and other single-use medical device items. Genesis Plastics Welding is a US-based medical equipment manufacturing company specializing in creating and developing unique single-use medical devices, including fluid bags.

Regional Outlook

North America was the largest region in the medical specialty bags market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Medical Specialty Bags Market?

The medical specialty bags market consists of sales of blood bags, nutrition bags, bioprocess bags and sterilization bags. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.